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Innate immune defense against microbial pathogens occurs by physical barriers, by recruitment of cells such as
neutrophils, NK cells, and macrophages, and by secretion of molecules with antimicrobial activity. Such molecules
are produced by various epithelia including skin. The importance of antimicrobial peptides has been shown in
cathelicidin-deﬁcient mice, which have increased susceptibility to skin infection by Streptococcus. Although kera-
tinocytes increase cathelicidin expression upon injury, their role relative to neutrophil cathelicidin and their sites of
peptide storage and activation have not been elucidated. Herein, it is reported that cathelicidin predominantly
resides in granules of the superﬁcial epidermis and partially localizes in lamellar bodies as determined by
immunogold electron microscopy and immunoblot of lamellar bodies isolated from mice. In cultured keratinocytes,
cathelicidin displays a granular distribution and partially localizes within the Golgi apparatus. Cathelicidin
processing can be observed by western blot analysis in keratinocyte extracts but not in conditioned media. Further,
ﬂuorescent bacteria colocalize with cathelicidin in granules both intracellularly and at the cell surface. These
observations illustrate the immune defense potential of keratinocytes acting directly through storage and process-
ing of antimicrobial peptides.
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The skin is positioned at the interface between an organ-
ism’s internal milieu and an external environment char-
acterized by constant assault with potential microbial
pathogens. Once considered merely as a physical protec-
tive barrier, it is now apparent that a major role of the skin is
to defend the body by rapidly mounting an innate immune
response to injury and microbial insult. Both resident skin
cells and recruited inflammatory cells, including keratin-
ocytes and neutrophils, respectively, synthesize antimicro-
bial peptides and various other host defense molecules that
together demonstrate broad-spectrum activity against bac-
teria, fungi, and viruses.
Two major families of small cationic antimicrobial pep-
tides have been best studied in mammalian skin: b-defen-
sins and cathelicidins. b-defensins form b-sheet structures
and contain multiple cysteine residues that form intermo-
lecular disulfide bridges (Lehrer and Ganz, 1999). Cathelici-
dins share a conserved cathelin pro-domain and a variable
antimicrobial peptide domain that is released from the par-
ent molecule by proteolytic processing (Zanetti et al, 2000).
Both infiltrating immune cells and resident epithelial cells
express these antimicrobial peptides. For example, human
b-defensin-1 (hBD-1) is constitutively made by keratin-
ocytes, whereas hBD-2, hBD-3, and the human cathelicidin
hCAP18/LL-37 are typically upregulated in keratinocytes
during inflammation and accumulate in the skin in part
through release by neutrophils.
The essential role of antimicrobial peptides in defense of
the skin against bacterial infection has been demonstrated
in mice deficient in the murine cathelicidin gene (Nizet et al,
2001) and in pig wounds inhibited from processing porcine
cathelicidins to their active peptide form (Cole et al, 2001).
Cathelicidins are derived from several cell types present in
the skin including keratinocytes (Frohm et al, 1997; Soren-
sen et al, 2003), neutrophils (Turner et al, 1998), mast cells
(Di Nardo et al, 2003), and eccrine glands (Murakami et al,
2002). Because of the various cellular sources of cathelici-
din and the multiple antimicrobial peptide families present in
skin, the relative contribution of keratinocyte cathelicidin to
epidermal barrier defense against infection is unclear.
Understanding the role of antimicrobial peptides in the
skin requires careful assessment of their production by the
epidermis. This stratified epithelial structure is comprised of
multiple keratinocyte layers in various states of differentia-
tion and with distinct potential functions. The granular layer
and stratum corneum consist of terminally differentiated
cells involved in superficial barrier formation (Norlen et al,
2003) and contain secretory granules called lamellar bodies.
These lipid-rich disks are bound by a single membrane,
range in size from 0.1 to 0.6 mm and release their contents
into intercellular spaces where stored hydrolytic enzymes
are activated and process polar lipids into the hydrophobic
products that constitute the stratum corneum (Madison
et al, 1998; Rassner et al, 1999). Lamellar bodies are se-
creted within 30 min and for at least 6 h following disruption
Abbreviations: LB, lamellar bodies; NHK, normal human keratin-
ocytes; pNPP, p-nitrophenyl phosphate; TRITC, tetramethylrhoda-
mine isothiocyanate
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of the permeability barrier (Menon et al, 1992; Nickoloff,
1999; Rassner et al, 1999). This timing is consistent with
antimicrobial peptide production following injury, and sug-
gests that an additional function of keratinocyte granules
may be to participate in innate immune defense. Consistent
with this hypothesis, lamellar bodies have recently been
shown to provide storage sites for b-defensins (Oren et al,
2003).
This study sought to characterize the intracellular sites of
keratinocyte cathelicidin expression and to evaluate the
antimicrobial function of keratinocytes in epidermal immune
defense. The results indicate that cathelicidin is present
in keratinocyte lamellar bodies, undergoes proteolytic
processing by keratinocytes, and associates with internal-
ized and cell surface bacteria. Keratinocyte synthesis of
cathelicidin may therefore play an important role in skin im-
munity by forming an active part of the antimicrobial def-
ense barrier that is independent of circulating immune cells.
Results
The intracellular localization of cathelicidin in human skin
was investigated by immunofluorescence microscopy of
cultured human skin constructs. These constructs consist
of normal human keratinocytes (NHK) grown and differen-
tiated on a fibroblast-populated collagen gel matrix and re-
semble in vivo skin structure, including stratum corneum
formation. Under these culture conditions, hCAP18/LL-37
reactivity was apparent in both basal and suprabasal ker-
atinocyte layers, although expression increased in differen-
tiated cell layers (Fig 1a). Expression in these layers
appeared to be localized mainly within cells, but scattered
expression in intercellular spaces within the stratum corn-
eum could also be appreciated. The keratinocyte differen-
tiation marker involucrin showed reactivity only in the
suprabasal layers of the epidermis and in the stratum corn-
eum (Fig 1b). When these images were merged, hCAP18/
LL-37 was found to partially colocalize with involucrin in
suprabasal keratinocytes by confocal microscopy (Fig 1c).
To further investigate hCAP18/LL-37 subcellular locali-
zation in keratinocytes, immunogold electron microscopy
was performed using the Apligraf human skin equivalent.
This commercial construct is similarly comprised of differ-
entiated keratinocytes grown on a fibroblast-populated ma-
trix. Immunogold electron microscopy revealed specific
labeling of hCAP18/LL-37 in granules, some of which dis-
played a characteristic lamellar structure (Fig 2). Identical
skin sections incubated with rabbit pre-immune serum were
negative (data not shown). Because of the electron micros-
copy processing techniques required to preserve cathelici-
din antigenicity, the lamellar structure could not be
observed in all cathelicidin-containing granules. Biochem-
ical lamellar body isolation techniques were therefore un-
dertaken to confirm the localization of cathelicidin in these
keratinocyte granules.
Lamellar bodies were enriched from adult wild-type
mouse skin by selective sequential filtration (Grayson
et al, 1983, 1985). Granule preparations were then concen-
trated and subjected to immunoblot analysis for detection
of the murine ortholog of hCAP18/LL-37 (mCRAMP) using a
polyclonal rabbit anti-mCRAMP antibody. Filtrates were si-
multaneously assayed for total and acid phosphatase ac-
tivity to confirm lamellar body enrichment in each fraction.
The mCRAMP antibody was reactive with lamellar body-
containing fractions, particularly the concentrated 430 kDa
filtrates, from mouse epidermis (Fig 3). Mouse bone marrow,
which expresses high levels of mCRAMP, along with syn-
thetic mCRAMP peptide, served as positive controls for
immunoblotting (data not shown). Since lamellar bodies are
Figure1
Colocalization of cathelicidin and involucrin in keratinocyte gran-
ules of cultured human skin constructs. Cultured skin constructs
were embedded in paraffin and sectioned for immunohistochemistry.
Sections were incubated with (a) polyclonal chicken anti-hCAP18/LL-
37 and (b) monoclonal mouse anti-involucrin, followed by donkey anti-
chicken tetramethylrhodamine isothiocyanate and goat anti-mouse
AlexaFluor488, respectively. Images were obtained using a laser scan-
ning confocal microscope. (c) Overlay of hCAP18/LL-37 and involucrin
images. The scale bars represent 20 mm.
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enriched in acid hydrolases, detection of increased total
phosphatase activity in the concentrated 430 kDa filtrates
confirmed that lamellar bodies were most abundant in these
mCRAMP-reactive filtrates (Fig 3). Additional experiments
to specifically evaluate acid phosphatase activity confirmed
that the total phosphatase detected in mCRAMP-reactive
fractions shown in Fig 3 represented acid hydrolase activity
(data not shown). These assays further support localization
of cathelicidin in keratinocyte lamellar bodies.
The subcellular distribution of cathelicidin in keratin-
ocytes grown on tissue culture plates was also investigated.
Immunofluorescence microscopy was performed on mono-
layer cultures of undifferentiated NHK or immortalized Ha-
CaT keratinocytes. Using antibodies against either hCAP18/
LL-37 or its conserved cathelin domain, cathelicidin was
observed in a punctate perinuclear distribution pattern in
cultured keratinocytes (Fig 4a). No differences in localization
were detected between hCAP18/LL-37 and the cathelin
domain or between NHK and HaCaT cells (data not shown).
Pre-immune chicken IgY controls were negative. The peri-
nuclear distribution pattern of cathelicidin resembled that of
the Golgi apparatus, so colocalization studies were per-
formed on NHK using a combination of antibodies recog-
nizing either hCAP18/LL-37 or the cytoplasmic Golgi 58K
Protein, a microtubule-binding protein that serves as a
marker for the Golgi apparatus. Immunofluorescence mi
croscopy suggested partial localization of keratinocyte cath-
elicidin within the Golgi apparatus (Fig 4b).
The expression and processing of cathelicidin by cult-
ured keratinocytes was further studied by western blot
analysis of keratinocyte extracts and their conditioned
media. Analysis of dilute keratinocyte extracts by direct
Figure 2
Subcellular localization of cathelicidin in lamellar bodies. Cultured
human skin constructs were fixed and processed for immunogold
electron microscopy using polyclonal rabbit anti-hCAP18/LL-37 and
goat anti-rabbit conjugated to colloidal gold. Electron micrographs
represent multiple independent images of keratinocyte granules. The
scale bars represent 0.1 mm.
Figure3
Detection of mCRAMP expression in lamellar body preparations.
Epidermis was obtained from wild-type mouse skin by overnight dis-
pase treatment. Lamellar bodies were isolated by selective sequential
filtration and concentrated using 30 kDa molecular weight cut-off
centrifugal filtration columns. Filtrates were immunoblotted using
polyclonal rabbit anti-mCRAMP and goat anti-rabbit horseradish
peroxidase and assayed for total phosphatase activity by measuring
p-nitrophenyl phosphate (pNPP) hydrolysis at 405 nm. Densitometry
was performed to quantify mCRAMP protein expression. Data are nor-
malized to arbitrary units based on maximum mCRAMP expression
detected by densitometry and maximum phosphatase activity detected
by pNPP hydrolysis and represent the average of two experiments.
Figure4
Expression of cathelicidin and colocalization with the Golgi appa-
ratus in cultured human keratinocytes. Normal human keratinocytes
were cultured to near confluence and fixed with methanol. (a) Keratin-
ocytes immunostained with chicken anti-hCAP18/LL-37 and donkey
anti-chicken tetramethylrhodamine isothiocyanate (TRITC). (b) Immu-
nostaining with both polyclonal chicken anti-hCAP18/LL-37 and mono-
clonal mouse anti-Golgi 58K Protein, followed by donkey anti-chicken
TRITC and goat anti-mouse AlexaFluor488, respectively. The scale bars
represent 20 mm.
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application to SDS-PAGE gels was limited by the sensitivity
of the Western blot and by the sample volume. Therefore,
extracts were immunoprecipitated using a polyclonal rabbit
anti-hCAP18/LL-37 antibody. Analysis of these immuno-
precipitated samples, as well as pure synthetic peptide or
recombinant protein, revealed expected bands correspond-
ing to the IgG used for the immunoprecipitation in addition
to bands at  18 and  5 kDa corresponding to the pre-
cursor form of cathelicidin (hCAP18) and the mature peptide
(LL-37), respectively (Fig 5). Cathelicidin was not detected in
immunoprecipitations of conditioned media. Based on the
LL-37 peptide control precipitated from an identical volume
of extraction buffer, the concentration of LL-37 in keratin-
ocyte extracts was estimated to be approximately 32 nM.
Upon confirmation of cathelicidin localization and
processing in keratinocytes, cathelicidin expression was
assessed upon incubation of keratinocytes with bacteria.
By confocal microscopy, keratinocytes were found to inter-
nalize heat-killed, fluorescent Escherichia coli BioParticles,
which colocalized with cathelicidin both intracellularly and
near the cell surface (Fig 6). The cell surface colocalization
may represent lamellar body secretion into intercellular
spaces near sites of bacterial contact with keratinocytes.
Discussion
Under inflammatory conditions, cathelicidin is deposited at
sites of injury by both neutrophils and keratinocytes. In
neutrophils, which contain up to 1.34 mM hCAP18/LL-37
during inflammation, cathelicidin is stored in secondary
(specific) granules. Neutrophil primary (azurophil) granules
contain various other antimicrobial peptides and processing
enzymes, including defensins, elastase, and proteinase 3
(Cowland et al, 1995; Sorensen et al, 1997; Turner et al,
1998). Specific granules generally secrete their contents
extracellularly, whereas azurophil granules deliver their con-
tents to intracellular phagolysosomes. Separation of cath-
elicidins from their corresponding processing enzymes
may function to maintain the peptides as an inactive pool
until proteolysis occurs during inflammation. Since keratin-
ocytes are not considered to be a major source of cath-
elicidin in normal skin, their relative contribution to cutaneous
host defense in comparison with traditional immune
effector cells such as neutrophils is unclear (Sorensen
et al, 1997). Therefore, this study set out to identify sites
of subcellular localization and activation of cathelicidin in
keratinocytes.
In previous studies, involucrin reactivity has primarily
been shown in granular layer keratinocytes and in the inner
stratum corneum; involucrin has also been detected in cy-
toplasmic granules of both the suprabasal epidermis and
cultured cells (Warhol et al, 1985; Murthy et al, 1993). Fur-
ther, lamellar granule-associated protein (LGP) is expressed
in coordination with the cornified cell envelope precursor
proteins involucrin and loricrin during epidermal develop-
ment (Akiyama et al, 1999). hCAP18/LL-37 colocalization
with involucrin suggests that cathelicidin is stored in gran-
ules, possibly lamellar bodies, and that cathelicidin expres-
sion increases during keratinocyte differentiation. Of note,
keratinocytes cultured as monolayers and stimulated to
differentiate solely by increasing calcium concentration do
not increase cathelicidin expression relative to cells grown
in low calcium conditions (Sorensen et al, 2003). Keratin-
ocytes must be cultured as three-dimensional skin con-
structs in order to achieve terminal differentiation and to
Figure 5
Expression and processing of cathelicidin in keratinocyte extracts
and conditioned media. HaCaT keratinocytes were cultured to con-
fluence, cell conditioned media was removed and keratinocytes were
extracted in 1% Triton X-100/phosphate-buffered saline. Western blot
and immunoprecipitations (IP) were performed with polyclonal rabbit
anti-hCAP18/LL-37. (a) Short exposure to illustrate hCAP18 and (b)
long exposure of same blot to illustrate LL-37 peptide. Lane 1, IP of cell
extract; Lane 2, IP of conditioned media; Lane 3, recombinant hCAP18/
LL-37 (not IP); Lane 4, synthetic LL-37 peptide (not IP); Lane 5, IP of
recombinant hCAP18/LL-37; Lane 6, IP of synthetic LL-37 peptide.
Figure6
Bacterial internalization and colocalization with cathelicidin in cul-
tured human keratinocytes. Confocal microscopy of foreskin-derived
normal human keratinocytes incubated overnight with Escherichia coli
tetramethylrhodamine isothiocyanate BioParticles. Cells were fixed in
methanol and immunostained with either chicken anti-hCAP18/LL-37 or
chicken anti-cathelin domain. Serial images representing 0.4 mm sec-
tions are numbered. The scale bar represents 10 mm. Bacterial particles
are red, cathelicidin is green, and yellow shows colocalization between
hCAP18/LL-37 and internalized or cell surface-bound bacteria.
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form lipid profiles that resemble in vivo skin (Uchida et al,
2001).
Some of the granules in which cathelicidin was detected
by immunogold electron microscopy displayed stacks of
lamellae, whereas other granules were the appropriate size
of lamellar bodies but lacked the characteristic internal
structure. The loss of lipid structures during cryopreserva-
tion and antigen retrieval is not uncommon during process-
ing for electron microscopy, so further experiments were
performed to confirm the presence of cathelicidin in lamellar
bodies isolated from skin. Since lamellar bodies are en-
riched in acid hydrolases, particularly glucosidase, acid
phosphatase, phospholipase A, and sphingomyelinase,
these enzymes serve as useful markers for identification
of these granules (Freinkel and Traczyk, 1983). Therefore,
phosphatase assays measuring hydrolysis of p-nitrophenyl
phosphate (pNPP), a phosphatase substrate, were per-
formed to complement the detection of cathelicidin in iso-
lated granules by immunoblot (Okawara et al, 1972; Freinkel
and Traczyk, 1981). Although these techniques are useful
for detecting cathelicidin expression and acid phosphatase
activity associated with lamellar bodies, they do not distin-
guish whether cathelicidin is bound to lamellar body mem-
branes or fully contained within these granules.
These studies suggest that cathelicidin partially localizes
to keratinocyte granules, including lamellar bodies. Some
staining is also seen in the intercellular spaces, which is
consistent with prior studies showing that cathelicidin is
deposited in the extracellular spaces of the stratum corn-
eum in a pattern similar to that shown for hBD-2 (Dorschner
et al, 2001; Liu et al, 2002; Oren et al, 2003). Lamellar bodies
may therefore act as storage sites for cathelicidin and offer
a potential mechanism for extracellular secretion of this
antimicrobial peptide upon injury or even during normal
keratinocyte differentiation and stratum corneum formation.
The recent detection of b-defensin storage in lamellar bod-
ies suggests that these granules comprise an important
source of skin antimicrobial peptides (Oren et al, 2003). The
Golgi origin of lamellar bodies further supports the finding
that cathelicidin localizes in both the Golgi apparatus of
cultured keratinocytes and in the lamellar bodies of differ-
entiated keratinocytes that comprise the skin (Madison et al,
1998).
The detection of proteolytically processed cathelicidin in
keratinocyte extracts suggests that keratinocytes have the
enzymatic machinery necessary for intracellular activation
of this antimicrobial peptide for potential function in skin
defense. Prior analysis of stratum corneum from normal and
virally infected skin has in fact shown that cathelicidin
present in this compartment is processed to the mature
 5 kDa form that is presumably LL-37 or a recently de-
scribed cathelicidin of similar size such as KS-30 or RK-31
(Conner et al, 2002; Murakami et al, 2004). The absence of
detectable levels of processed LL-37 in keratinocyte con-
ditioned medium may be because of the predominance of
intracellular activation and antimicrobial activity, the pres-
ence of protease inhibitors or LL-37 binding proteins in the
intercellular space, or the degradation of LL-37 upon se-
cretion from keratinocytes. Further, intercellular LL-37 se-
cretion and processing may only occur in response to an
inflammatory stimulus such as skin injury or bacterial infec-
tion. The confocal microscopy data showing that keratin-
ocytes internalize bacteria, which then partially colocalize
with granular cathelicidin, suggests a direct role for intra-
cellular cathelicidin processing in keratinocytes antimicro-
bial activity. Experiments aimed to determine the relative
contribution of cathelicidin to keratinocyte antimicrobial ac-
tivity are currently underway.
In conclusion, keratinocytes synthesize, store and acti-
vate cathelicidin antimicrobial peptides. Keratinocytes also
internalize bacteria, which colocalize with endogenous cath-
elicidin. These observations illustrate the potential contri-
bution of keratinocytes to cutaneous defense and confirm
the role of the epidermis as an independent direct immune
barrier. The clinical consequences of defective antimicrobial
peptide production by the epidermis are evident in atopic
dermatitis patients, who lack the ability to normally increase
antimicrobial peptide release during inflammation and have
a greatly increased risk of infection (Ong et al, 2002). There-
fore, understanding the regulation of keratinocyte-derived
antimicrobial peptides may have an important role in the
treatment of skin disease.
Materials and Methods
Immunoﬂuorescence microscopy of skin constructs Skin con-
structs were generated by growing and differentiating primary ker-
atinocytes on a collagen-embedded fibroblast matrix for 10 d as
previously described (Watson et al, 1994; Ponec et al, 2002). Con-
structs were paraffin-embedded, fixed in paraformaldehyde, and
sectioned for immunohistochemistry. Following hydration and an-
tigen retrieval steps, sections were blocked with 5% donkey se-
rum/goat serum and then incubated simultaneously with polyclonal
chicken anti-hCAP18/LL-37 and monoclonal mouse anti-involucrin
primary antibodies. Donkey anti-chicken tetramethylrhodamine iso-
thiocyanate (TRITC) and goat anti-mouse IgG conjugated to Ale-
xaFluor488 (Molecular Probes, Eugene, Oregon) were used as
secondary antibodies, respectively. Sections were mounted in
ProLong Anti-Fade reagent (Molecular Probes). Images were ob-
tained using a Zeiss LSM510 laser scanning confocal microscope
(Carl Zeiss Light Microscopy, Go¨ttigen, Germany) coupled with an
Axiovert 100 (Carl Zeiss) inverted stage microscope.
Immunogold electron microscopy Immunogold electron micros-
copy was performed using Apligraf human skin constructs (Or-
ganogenesis, Canton, Massachusetts). Briefly, samples were fixed
overnight at 41C in Immunofix containing 0.5% glutaraldehyde and
then transferred to 0.1 M cacodylate buffer (pH 7.4) containing 0.1
M glycine for 15 min at room temperature. Samples were dehy-
drated to 50% ethanol, incubated for 30 min in 70% ethanol con-
taining 0.2% uranyl acetate, and further dehydrated to 95%
ethanol. Samples were then placed in a 1:1 mixture of LR White
resin (Ted Pella Inc., Redding, California) in 95% ethanol, rotated
overnight at room temperature, and infiltrated with 100% LR White
resin for another 7 h. Strips of Apligraf were placed in gelatin cap-
sules that were quickly filled with resin to which LR White Accel-
erator had been added (one drop accelerator per 10 mL resin).
Blocks hardened within 15 min and sections were collected on 1%
parlodion-coated nickel grids. Immunogold labeling was per-
formed as previously described (Deftos et al, 1993; Springer and
Haywood-Reid, 1993), using a 1:5 dilution of polyclonal rabbit anti-
hCAP18/LL-37 antibody and goat anti-rabbit IgG conjugated to
colloidal gold. Rabbit pre-immune serum served as a negative
control. Immunogold-labeled grids were examined using a Zeiss
EM10B electron microscope at an accelerating voltage of 60 kV
(VASDHS Core Imaging Facility, San Diego, California).
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Lamellar body isolation by selective sequential ﬁltration Lam-
ellar bodies were isolated by selective sequential filtration as
previously described (Grayson et al, 1983, 1985). Briefly, skin was
removed from adult mice and the epidermis was separated from
the dermis by overnight treatment with dispase (Roche, India-
napolis, Indiana). The isolated intact epidermis was then homo-
genized in a ground glass Dounce homogenizer, sonicated, and
centrifuged at 700  g for 10 min to pellet cell debris. The lamellar
body-containing supernatant was then passed through a series of
membrane filters, including 10, 5, 3, 1.2, 0.8, 0.6, 0.4, and 0.2mm
sizes (Millipore, Bedford, Massachusetts). Filtrates were collected
following passage through the 0.6, 0.4, and 0.2 mm filters. BCA
assays were performed to confirm equal protein loading among
filtrates. These filtrates were then applied to 30 kDa molecular
weight cut-off Microcon centrifugal filter devices (Millipore) in order
to trap lamellar bodies whereas allowing passage of soluble cath-
elicidin peptides that were not associated with lamellar bodies.
Fractions from the 0.6, 0.4, 0.2 mm, and 30 kDa filtrates were as-
sayed by immunodot blot analysis to detect cathelicidin protein
expression and by acid phosphatase assay to confirm lamellar
body isolation. Animal use was done with approval of the VA San
Diego Animal Use Subcommittee.
Immunodot blot analysis Expression of cathelicidin was evalu-
ated in sequential size filtrates by immunodot blot analysis.
mCRAMP synthetic peptide and mouse bone marrow served as
positive controls. Briefly, filtrates were diluted in 1 mM TBS and
blotted onto a nitrocellulose membrane. The membrane was
blocked with 5% non-fat milk for 1 h at room temperature and
incubated with polyclonal rabbit anti-mCRAMP antibody diluted in
blocking solution for an additional hour at room temperature. The
membrane was then incubated with goat anti-rabbit horseradish
peroxidase antibody in blocking solution for 1 h at room temper-
ature. Three 5-min washes were performed after each antibody
step using 0.1% TBS-Tween. Blots were developed using standard
chemiluminescence reagents (Perkin-Elmer Life Sciences, Boston,
Massachusetts). Densitometry measurements were obtained using
ChemiImager 4400 (Alpha Innotech, San Leandro, California).
Acid phosphatase assay General phosphatase activity was as-
sessed in sequential size filtrates by measuring pNPP hydrolysis
according to the manufacturer’s instructions (Upstate Biotechnol-
ogy, Lake Placid, New York). Briefly, each reaction mixture con-
tained 40 mM NiCl2, 5 mg mL BSA, lamellar body preparation
(enzyme), pNPP Ser/Thr Assay Buffer (50 mM Tris-HCl, 0.1 mM
CaCl2, pH 7.0) and 1.5 mg mL pNPP substrate. Reaction mixtures
were incubated at 371C for 20 min prior to substrate addition and
for various time periods following substrate addition. Kinetic ab-
sorbance measurements were taken at 405 nm. An increase in
absorbance units over time reflects phosphatase activity and in-
dicates the presence of lamellar bodies. Acid phosphatase activity
was specifically measured using the Enzchek Acid Phosphatase
Assay Kit according to the manufacturer’s instructions (Molecular
Probes).
Cell culture NHK were cultured in EpiLife cell media containing
0.06 mM Ca2þ , 1  EpiLife defined growth supplement, 50 U mL
penicillin, and 50 mg mL streptomycin. HaCaT keratinocytes were
cultured in DMEM cell media containing 10% fetal bovine serum,
2 mM L-glutamine, 50 U mL penicillin, and 50 mg mL streptomycin.
Keratinocytes were grown at 371C under standard tissue culture
conditions.
Immunoﬂuorescence microscopy of cultured keratinocytes NHK
were grown to 80% confluence on glass coverslips and fixed in
methanol for 30 min at 41C. Cells were blocked with 5% donkey
serum for 30 min, followed by a 1-h incubation with polyclonal
chicken anti-hCAP18/LL-37 antibody and a 30-min incubation with
donkey anti-chicken TRITC antibody. In Golgi colocalization exper-
iments, NHK were incubated with both polyclonal chicken anti-
hCAP18/LL-37 and monoclonal mouse anti-Golgi 58K Protein
(Sigma, St Louis, Missouri). The Golgi 58 K Protein is a 58 kDa
microtubule-binding protein located on the peripheral Golgi mem-
brane. Donkey anti-chicken TRITC and goat anti-mouse IgG conju-
gated to AlexaFluor488 were used as secondary antibodies,
respectively. Images were obtained using an Olympus BX41
fluorescent microscope (Scientific Instrument Company, Temecula,
California).
Immunoprecipitation and western blot analysis To evaluate the
expression of cathelicidin in keratinocytes, HaCaT keratinocytes
were cultured to confluence in a 10-cm dish. Conditioned media
was removed and stored on ice whereas cells were scraped from
the plastic and extracted in 1% Triton-X 100/phosphate-buffered
saline (PBS). Both keratinocyte extracts and conditioned media
were sonicated on ice and spun down at 14,000  g for 10 min. To
immunoprecipitate, 1 mL keratinocyte extract and conditioned
media were incubated for 1 h on ice with 1 mg rabbit anti-LL-37
polyclonal antibody, followed by overnight incubation at 41C with
Protein A-Agarose beads (Roche, Indianapolis, Indiana). Both full-
length hCAP18/LL-37 and LL-37 peptide were used as positive
controls. After several washes, samples were resuspended in SDS
loading buffer and boiled for 10 min prior to loading on a 16% Tris-
Tricine gel. The gel was run at 100 V for 1 h at room temperature
and then transferred onto a nitrocellulose membrane at 100 V on
ice for another hour. The membrane was blocked and then probed
with 1:5000 rabbit anti-LL-37 and 1:5000 goat anti-rabbit horse-
radish peroxidase for 1 h each prior to developing with standard
chemiluminescence reagents.
Bacterial internalization by confocal microscopy NHK were
grown to 50% confluence and incubated overnight with E. coli
TRITC BioParticles bacteria (Molecular Probes). Cells were
washed, fixed in cold methanol and immunostained as described
above using either polyclonal chicken anti-hCAP18/LL-37 or po-
lyclonal chicken anti-cathelin domain, followed by goat anti-chick-
en fluorescein isothiocyanate. Images were obtained using a Zeiss
LSM510 laser scanning confocal microscope coupled with an Axio-
vert 100 inverted stage microscope.
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